News Releases

News and information from The Leukemia & Lymphoma Society

LLS and Partners Commit $4.5 Million For Blood Cancer Patients Impacted By COVID-19

Rye Brook, NY – April 1, 2020 – In the wake of the COVID-19 pandemic, The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer, along with valued partners, announced their commitment to help as many blood cancer patients as possible during this unprecedented crisis. The LLS COVID-19 Patient Financial Aid Program will begin immediately to provide $250 to eligible patients struggl...

29 Patient Organizations Urge Lawmakers to Take Bold, Immediate Action to Protect Those Most Vulnerable to COVID-19

Washington, D.C. (March 16, 2020) – Twenty-nine organizations representing millions of patients diagnosed with serious health conditions urge the U.S. Senate to immediately pass the U.S. House-approved coronavirus bill and take additional critical steps. In a letter to Senate Majority Leader Mitch McConnell and Senate Minority Leader Chuck Schumer, the organizations emphasize the importance of enacting...

LLS Announces New Chief Operating Officer, Chief Marketing Officer and General Counsel

Rye Brook, NY, (March 2, 2020) – The Leukemia & Lymphoma Society (LLS) announced today three new appointments to its leadership team, Troy Dunmire, EVP, chief operating officer, Lynn Godfrey, EVP, chief marketing officer and Dale Nissenbaum, EVP, general counsel. “I’m pleased to announce significant new leadership appointments at The Leukemia & Lymphoma Society (LLS), leaders who join our strong exec...

Short-Term Health Plans Leave Patients Vulnerable to Major Medical Bills, According to New Research

View full news release here. Washington, D.C. (February 25, 2020) – The Leukemia & Lymphoma Society (LLS) released today new research which shows the significant financial costs facing consumers treated for five serious conditions while enrolled in short-term health plans: lymphoma, heart attack, lung cancer, diabetes and mental health hospitalizations. The study, conducted by actuarial fir...

24 Patient Groups Endorse Expedited Supreme Court Review of ACA Case

WASHINGTON, D.C. (January 3, 2020) — Twenty-four organizations representing millions of patients strongly support the petitions filed today by state attorneys general and by the U.S. House of Representatives that seek expedited U.S. Supreme Court review of last month’s Texas v. United States ruling. The coalition issued the following statement: “Our organizations, representing millions of individuals and ...

Burlington Stores Raises More Than $5.8 Million For LLS This Year

Rye Brook, NY, (January 7, 2020) – Burlington Stores and The Leukemia & Lymphoma Society (LLS) teamed up for the 18th consecutive year to raise critical funds for cancer research and patient support to help save lives and bring smiles to those impacted. From September 9 through December 2, customers at Burlington’s more than 700 locations nationwide were encouraged to donate $1 or more at checkout to support ...

28 Patient Groups Disappointed in 5th Circuit Court Ruling in Texas v. U.S.

Washington, D.C., (December 19, 2019) — Yesterday, the U.S. Court of Appeals for the Fifth Circuit issued their ruling in Texas v. United States, striking down the Affordable Care Act’s individual mandate and remanding back to the district court the decision as to whether key patient protections will remain in the future. In response, more than 25 patient groups issued the following statement: “It is importa...

LLS and ASH Team Up to Connect Cancer Patients to Clinical Trials

Collaboration will provide critical clinical trial navigation services and support to patients and families Rye Brook, NY, (December 6, 2019) -  The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) announced today a collaboration to expand access to LLS’s unique free service providing clinical trials navigation and support to blood cancer patients and their families. With o...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: